Data coverage, completeness and provenance for RACURA ONCOLOGY LTD in the Stock Market API — Health Care · Biotechnology.
Source date: 2026-10-30T05:10:11. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-10-30 | 1.5450 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-29 | 1.5500 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-28 | 1.5150 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-27 | 1.5350 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-26 | 1.6450 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/RAC/prices · Price parameters and adjustment semantics
Racura Oncology Ltd operates as a clinical-stage biopharmaceutical company in Australia. It develops RC220, a formulation of (E,E)-bisantrene, which is in Phase III clinical trial for the treatment of acute myeloid leukemia; Phase Ia/b clinical trial for the treatment of epidermal growth factor receptor-mutated non-small cell lung cancer; and Phase Ia/b clinical trial for the treatment of solid tumor cancers. The company was formerly known as Race Oncology Limited and changed its name to Racura Oncology Ltd in December 2025. Racura Oncology Ltd was incorporated in 2011 and is headquartered in Sydney, Australia.
Website: https://racuraoncology.com · Profile fields populated: 60%
Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/RAC/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2026 (AUD) | 2026-06-30 | 24 | yfinance | ||||
| FY2025 (AUD) | 2025-06-30 | 22 | yfinance | ||||
| FY2024 (AUD) | 2024-06-30 | 21 | yfinance | ||||
| FY2023 (AUD) | 2023-06-30 | 21 | yfinance |
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/RAC
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/RAC/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/RAC/metrics/summary
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/RAC/filings
Dated press releases and announcements with source links.
GET /api/v1/companies/RAC/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/RAC
Free tier — instant API key. Built for AI agents.